Burton H. Jaynes

622 total citations
14 papers, 347 citations indexed

About

Burton H. Jaynes is a scholar working on Pharmacology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Burton H. Jaynes has authored 14 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 5 papers in Organic Chemistry and 4 papers in Molecular Biology. Recurrent topics in Burton H. Jaynes's work include Inflammatory mediators and NSAID effects (3 papers), Oxidative Organic Chemistry Reactions (2 papers) and Microbial Natural Products and Biosynthesis (2 papers). Burton H. Jaynes is often cited by papers focused on Inflammatory mediators and NSAID effects (3 papers), Oxidative Organic Chemistry Reactions (2 papers) and Microbial Natural Products and Biosynthesis (2 papers). Burton H. Jaynes collaborates with scholars based in United States. Burton H. Jaynes's co-authors include Frederick E. Ziegler, Manohar Saindane, Martin R. Jefson, Scott J. Hecker, James W. McFarland, S Froshauer, Shigeru Hayashi, Kristin M. Lundy, Barbara J. Kamicker and Chi B. Vu and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Burton H. Jaynes

14 papers receiving 331 citations

Peers

Burton H. Jaynes

PHARM

POLLU

SPECT

John M. Clancy Ireland

B Marciniec Poland

Daniel S. Torok United States

Nobuyuki Takeda Japan

François Estour France

Lokesh Chandra Mishra India

Christopher K. Jankowski Canada

Thomas H. Eichhold United States

Pierre‐Loïc Saaidi France

H. L. HOLLAND Canada

John M. Clancy Ireland

Burton H. Jaynes

116 ×0.7

121 ×1.5

75 ×1.1

PHARM

12 ×0.2

POLLU

25 ×0.6

SPECT

Citations per year, relative to Burton H. Jaynes Burton H. Jaynes (= 1×) peers John M. Clancy

Countries citing papers authored by Burton H. Jaynes

Since Specialization

Citations

This map shows the geographic impact of Burton H. Jaynes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Burton H. Jaynes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Burton H. Jaynes more than expected).

Fields of papers citing papers by Burton H. Jaynes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Burton H. Jaynes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Burton H. Jaynes. The network helps show where Burton H. Jaynes may publish in the future.

Co-authorship network of co-authors of Burton H. Jaynes

This figure shows the co-authorship network connecting the top 25 collaborators of Burton H. Jaynes. A scholar is included among the top collaborators of Burton H. Jaynes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Burton H. Jaynes. Burton H. Jaynes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Li, Jin, Brian S. Bronk, John P. Dirlam, et al.. (2007). In vitro and in vivo profile of 5-[(4′-trifluoromethyl-biphenyl-2-carbonyl)-amino]-1H-indole-2-carboxylic acid benzylmethyl carbamoylamide (dirlotapide), a novel potent MTP inhibitor for obesity. Bioorganic & Medicinal Chemistry Letters. 17(7). 1996–1999. 13 indexed citations

Sakya, Subas M., Andrei Shavnya, Hengmiao Cheng, et al.. (2007). Comparative structure–activity relationship studies of 1-(5-methylsulfonylpyrid-2-yl)-5-alkyl and (hetero)aryl triazoles and pyrazoles in canine COX inhibition. Bioorganic & Medicinal Chemistry Letters. 18(3). 1042–1045. 10 indexed citations

Li, Jin, Peter Bertinato, Hengmiao Cheng, et al.. (2006). Discovery of potent and orally active MTP inhibitors as potential anti-obesity agents. Bioorganic & Medicinal Chemistry Letters. 16(11). 3039–3042. 7 indexed citations

Sakya, Subas M., Xinjun Hou, Martha L. Minich, et al.. (2006). 5-Heteroatom substituted pyrazoles as canine COX-2 inhibitors. Part III: Molecular modeling studies on binding contribution of 1-(5-methylsulfonyl)pyrid-2-yl and 4-nitrile. Bioorganic & Medicinal Chemistry Letters. 17(4). 1067–1072. 28 indexed citations

Shavnya, Andrei, et al.. (2005). Efficient fluoride-mediated synthesis of 5-alkyl amino- and ether-substituted pyrazoles. Tetrahedron Letters. 46(40). 6887–6891. 18 indexed citations

Li, Jin, Michael P. Lynch, Subas M. Sakya, et al.. (2004). In vitro and in vivo profile of 2-(3-di-fluoromethyl-5-phenylpyrazol-1-yl)-5-methanesulfonylpyridine, a potent, selective, and orally active canine COX-2 inhibitor. Bioorganic & Medicinal Chemistry. 13(5). 1805–1809. 8 indexed citations

McFarland, James W., Cynthia M. Berger, S Froshauer, et al.. (1997). Quantitative Structure−Activity Relationships among Macrolide Antibacterial Agents: In Vitro and in Vivo Potency against Pasteurella multocida. Journal of Medicinal Chemistry. 40(9). 1340–1346. 123 indexed citations

McFarland, James W., Scott J. Hecker, Burton H. Jaynes, et al.. (1997). Repromicin Derivatives with Potent Antibacterial Activity against Pasteurella multocida. Journal of Medicinal Chemistry. 40(6). 1041–1045. 7 indexed citations

Jaynes, Burton H., et al.. (1994). Efficient Preparation of Hygromycin A Aglycon and Its Antibacterial 4'-Allyl Ether, CP-111905. The Journal of Organic Chemistry. 59(5). 1224–1225. 4 indexed citations

10.

Jaynes, Burton H., Christopher B. Cooper, Scott J. Hecker, et al.. (1993). Synthesis and vitro antibacterial activity of hygromycin a analogs modified at the C4′ aryl position. Bioorganic & Medicinal Chemistry Letters. 3(8). 1531–1536. 10 indexed citations

11.

Ziegler, Frederick E. & Burton H. Jaynes. (1988). Formation of (±)-forskolin via a cuprate addition to a synthetic dihydropyran-4-one. Tetrahedron Letters. 29(17). 2031–2032. 24 indexed citations

12.

Ziegler, Frederick E. & Burton H. Jaynes. (1987). Reconstitution of forskolin from a ring C dihydropyran-4-one degradation product thereof. Tetrahedron Letters. 28(21). 2339–2342. 17 indexed citations

13.

Ziegler, Frederick E., Burton H. Jaynes, & Manohar Saindane. (1987). A synthetic route to forskolin. Journal of the American Chemical Society. 109(26). 8115–8116. 74 indexed citations

14.

Ziegler, Frederick E. & Burton H. Jaynes. (1985). Rearrangement of a hindered allylic alcohol during vanadium-catalyzed epoxidation. A short synthesis of uvidin-c.. Tetrahedron Letters. 26(48). 5875–5878. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact